12
Participants
Start Date
August 30, 2017
Primary Completion Date
December 10, 2020
Study Completion Date
December 10, 2020
ABY-029
A minimum of 6 and a maximum of 12 adult patients with a diagnosis of primary soft-tissue sarcoma will be enrolled. Initial diagnostic biopsy specimens will be analyzed for EGFR positivity (an EGFR pathology score ≥ 1) by immunohistochemistry following routine diagnostic processing by Pathologist. Patients will be administered a single intravenous dose of ABY-029 1-3 hours before surgery.
Dartmouth-Hitchcock Medical Center, Lebanon
Dartmouth College
OTHER
Dartmouth-Hitchcock Medical Center
OTHER